pHIV-1_pr45I-76F


Product Description

Ref-SKU:
006N-01988
Plasmid contains the entire genome of HIV-1 (NL4-3) with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 protease inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on protease inhibitors with virologic therapy failure.
Product Risk Group: 

Information on the related virus

Subspecies: 
Strain: 
Isolate: 


Unit definition: 
10 µg purified DNA in TE Buffer

In stock

675,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Cloned Product: Yes
Can it be used to produce GMO: 
No
Biosafety restrictions: 
Plasmid contains the entire genome of HIV-1 (NL4-3) with specific mutations in the protease gene, which can confer drug resistance to specific protease inhibitors. Might produce infectious virus after transfection into suitable human cells.
Region encompassed in this Product: 
entire HIV-1 genome
Plasmid: 
Plasmid selection: 
TAG: 
Sequencing: 
Fully sequenced
Sequence controlled: 
Yes
Mutations: 
No mutation compared to the reference sequence
Nucleic Acid preparation technique: 
ion exchange column (Macherey Nagel)
Storage conditions: 
TE Buffer -20C
Shipping conditions: 
IATA Classification: